Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?
Ontology highlight
ABSTRACT: Magnetic Resonance-guided Focused Ultrasound (MRgFUS) represents an effective micro-lesioning approach to target pharmaco-resistant tremor, mostly in patients afflicted by essential tremor (ET) and/or Parkinson's disease (PD). So far, experimental protocols are verifying the clinical extension to other facets of the movement disorder galaxy (i.e., internal pallidus for disabling dyskinesias). Aside from those neurosurgical options, one of the most intriguing opportunities of this technique relies on its capability to remedy the impermeability of blood-brain barrier (BBB). Temporary BBB opening through low-intensity focused ultrasound turned out to be safe and feasible in patients with PD, Alzheimer's disease, and amyotrophic lateral sclerosis. As a mere consequence of the procedures, some
SUBMITTER: Stefani A
PROVIDER: S-EPMC8990810 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA